Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Newman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Pharmaceutical Research|February 22, 2008
A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitoninAndrew Clark, Mei-Chang Kuo, Stephen Newman, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Editorial: Standards for lung imaging techniquesBeth L Laube, Timothy E Corcoran, Sunalene G Devadason, et al.
Respiratory Medicine|March 15, 2011
Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPDThomas Meyer, Peter Reitmeir, Peter Brand, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled productsJohn Fleming, Dale L Bailey, Hak-Kim Chan, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled productsSunalene G Devadason, Hak-Kim Chan, Sabine Haeussermann, et al.
American Journal of Therapeutics|March 5, 2004
Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhalerShashank Rohatagi, Sunny Chapel, Stephane Kirkesseli, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 12, 2008
Frequency and adequacy of depression treatment in a Canadian population sampleEleonora Esposito, Jian Li Wang, Carol E Adair, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled productsStephen Newman, William D Bennett, Martyn Biddiscombe, et al.
Neuroimage. Clinical|May 8, 2024
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Niels Bergsland, Dejan Jakimovski, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 2, 2011
Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary reportDennis O'Connor, Wallace P Adams, Mei-Ling Chen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Pharmaceutical Research|February 22, 2008
A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitoninAndrew Clark, Mei-Chang Kuo, Stephen Newman, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Editorial: Standards for lung imaging techniquesBeth L Laube, Timothy E Corcoran, Sunalene G Devadason, et al.
Respiratory Medicine|March 15, 2011
Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPDThomas Meyer, Peter Reitmeir, Peter Brand, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled productsJohn Fleming, Dale L Bailey, Hak-Kim Chan, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled productsSunalene G Devadason, Hak-Kim Chan, Sabine Haeussermann, et al.
American Journal of Therapeutics|March 5, 2004
Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhalerShashank Rohatagi, Sunny Chapel, Stephane Kirkesseli, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 12, 2008
Frequency and adequacy of depression treatment in a Canadian population sampleEleonora Esposito, Jian Li Wang, Carol E Adair, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2012
Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled productsStephen Newman, William D Bennett, Martyn Biddiscombe, et al.
Neuroimage. Clinical|May 8, 2024
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Niels Bergsland, Dejan Jakimovski, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 2, 2011
Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary reportDennis O'Connor, Wallace P Adams, Mei-Ling Chen, et al.
Pageof 2